Ovarian Cancer Symptoms and Risk Factors to Know

Knowing the signs of ovarian cancer and any inherited or lifestyle risks are key to early detection and treatment.

1:00 PM

Author | Kevin Joy

Grey background and light teal and dark teal drawing of ovaries

This article was updated on September 23, 2020.

Because there is no early detection test and most cases are found at advanced stages, ovarian cancer is particularly dangerous.

Ovarian cancer is the No. 1 cause of gynecologic cancer deaths and the fifth-highest cause of cancer deaths in women.

Although some risk factors are known, the disease shouldn't be ignored.

"All women have the potential to get ovarian cancer," says Karen McLean, M.D., Ph.D., a gynecologic oncologist at the University of Michigan Rogel Cancer Center. "Two of the most important things women can do are listen to their bodies and know their personal risks of getting the cancer."

Ovarian cancer develops in the ovaries, fallopian tubes or the lining of the abdomen. The resulting cancer cells often float free and attach elsewhere in the body, which can prompt bloating, feelings of fullness and changes in bowel habits.

A woman should call her doctor if any symptoms persist for several weeks.

We're understanding more and more about the genetics of the disease, not only about when it runs in families but also how mutations in the cancer can be targeted with specific medicines as better treatments for women.
Karen McLean, M.D., Ph.D.

LISTEN UP: Add the new Michigan Medicine News Break to your Alexa-enabled device, or subscribe to our daily audio updates on iTunes, Google Play and Stitcher.

"The earlier we detect the cancer, the more treatable it is," says McLean, who leads the Ovarian Cancer Initiative at Michigan Medicine. The program fights for the lives of women with ovarian cancer through exemplary clinical care, a focus on patient quality of life and groundbreaking research and education.

For those diagnosed with ovarian cancer, it's crucial to work with a gynecologic oncologist, McLean says. These specialists, she notes, are trained to guide treatment — typically both surgery and chemotherapy.

MORE FROM MICHIGAN: Subscribe to our weekly newsletter

Says McLean: "We're understanding more and more about the genetics of the disease, not only about when it runs in families but also how mutations in the cancer can be targeted with specific medicines as better treatments for women."

( The University of Michigan Rogel Cancer Center)

For more information about ovarian cancer, call the Cancer AnswerLine at 800-865-1125.

SOURCES: American Cancer Society,


More Articles About:

Cancer Care Ovarian Cancer Cancer and Genetics Cancer Counseling Cancer Risk Factors Cancer: Cancer Types
Health Lab word mark overlaying blue cells

Health Lab

Explore thousands of health news & research stories by visiting the Health Lab homepage for more.

Media Contact

University Hospital at U-M Health in the spring with flowering trees in foreground and Survival Flight helicopter visible

Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe

Featured News & Stories

Three people stand arm in arm with backs to camera studying a wall of family mementos
Health Lab

Online resources and coaching helped people seek genetic testing for cancer

New study from researchers at the University of Michigan Rogel Cancer Center showed an online resource and phone-based coaching both helped increase rates of genetic testing.
Health Lab

Liver cancer can be preventable. Do you know the treatable risk factors?

Learn about the risks of chronic liver disease, the treatable liver disease factors and how rates of liver cancer have increased.
Health Lab

Prostate cancer and hereditary risk: A doctor explains the connection

Some genetic mutations linked to breast cancer also can affect men, but in a different way. A Michigan Medicine urologist explains the connection.
News Release

Rogel research team receives $3. 2 M grant to cascade genetic testing to relatives

A team of researchers based at the University of Michigan Rogel Cancer Center and Stanford University received $3.2 million from the National Cancer Institute for a clinical trial to help patients with a hereditary-based cancer diagnosis extend genetic testing to at-risk relatives.
purple yellow red cells up close
Health Lab

Study explains how colorectal cancer cells maintain high iron levels

How colorectal cancer cells maintain high iron levels, according to Michigan Medicine research.
yellow black purple red cell in middle mostly black
Health Lab

Study sheds light on how early pancreas lesions become cancerous

Why many precursor lesions never develop into pancreatic cancer, according to findings from Michigan Medicine.